DISTRIBUTION OF PT IN THE URINE AND KIDNEY OF THE CISPLATIN TREATED RAT

被引:14
作者
MASON, RW
HOGG, SJ
EDWARDS, IR
机构
关键词
D O I
10.1016/0300-483X(86)90123-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:219 / 226
页数:8
相关论文
共 14 条
[1]   CISPLATIN METABOLITES IN PLASMA, A STUDY OF THEIR PHARMACOKINETICS AND IMPORTANCE IN THE NEPHROTOXIC AND ANTITUMOUR ACTIVITY OF CISPLATIN [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (19) :3063-3070
[2]   THE MECHANISM OF RENAL CLEARANCE OF CISPLATIN (CIS-DICHLORODIAMMINE PLATINUM-II) AND ITS MODIFICATION BY FUROSEMIDE AND PROBENECID [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (13) :2243-2246
[3]   CISPLATIN METABOLITES - A METHOD FOR THEIR SEPARATION AND FOR MEASUREMENT OF THEIR RENAL CLEARANCE INVIVO [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (01) :181-184
[4]  
DENTINO M, 1978, CANCER, V41, P1274, DOI 10.1002/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO
[5]  
2-F
[6]  
EINHORN LH, 1979, CANCER TREAT REP, V63, P1659
[7]  
GONZALEZVITALE JC, 1977, CANCER, V39, P1362, DOI 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO
[8]  
2-N
[9]  
KAUFFMAN GB, 1963, INORG SYNTH, V7, P241
[10]  
LEROY AF, 1980, CANCER TREAT REP, V64, P123